| Zacks Company Profile for Eisai Co., Ltd. (ESAIY : OTC) |
|
|
| |
| • Company Description |
| Eisai Co. Ltd. engages in the research and development, manufacture, sale and import and export of pharmaceuticals principally in Japan. It offers Dayvigo, for the treatment of insomnia. The company also provides Methycobal for the treatment of peripheral neuropathy; Jyseleca, a janus kinase inhibitor; Goofice for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, treatment for dementia; and Chocola BB plus for the preparation vitamin B2. Eisai Co. Ltd. is based in Tokyo, Japan.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $8.82 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 96,080 shares |
| Shares Outstanding: 1,166.60 (millions) |
| Market Capitalization: $10,289.39 (millions) |
| Beta: 0.31 |
| 52 Week High: $10.37 |
| 52 Week Low: $5.94 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
14.84% |
12.82% |
| 12 Week |
20.36% |
9.33% |
| Year To Date |
37.33% |
23.03% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
-
-
-,- -
- |
ph: -
fax: - |
None |
None |
|
|
| |
| • General Corporate Information |
Officers
- - -
- - -
- - -
- - -
- - -
|
|
Peer Information
Eisai Co., Ltd. (GSAC)
Eisai Co., Ltd. (CASI)
Eisai Co., Ltd. (ALCD.)
Eisai Co., Ltd. (OMNN)
Eisai Co., Ltd. (CGPI.)
Eisai Co., Ltd. (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 28258A107
SIC: -
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 06/01/24
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 1,166.60
Most Recent Split Date: (:1)
Beta: 0.31
Market Capitalization: $10,289.39 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.07 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $0.26 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
